Samsung C&T (028260) Stock Outlook 2026: Samsung Group's Governance Keystone
Samsung C&T (KS:028260) 2026 analysis for global investors. Samsung Group holding structure, 43% stake in Samsung Biologics, Samsung Bioepis 100%, trading/construction/fashion own-business EBITDA, NAV discount mechanics, and KRX trading considerations for non-Korean investors.
028260 Samsung CNT Korean Stocks